Overview

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the single-dose Bioavailability of Kali and G.D. Searle, Inc.
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Algorithme Pharma Inc
Treatments:
Metronidazole